Immediate Impact
4 by Nobel laureates 53 standout
Citing Papers
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
2025 Standout
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Works of Sommer E. Gentry being referenced
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
2021 Standout
Correcting the sex disparity in MELD-Na
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sommer E. Gentry | 1328 | 1117 | 1016 | 1073 | 72 | 2.3k | |
| Thomas G. Peters | 824 | 888 | 390 | 813 | 71 | 2.2k | |
| Paolo R. Salvalaggio | 1197 | 685 | 701 | 939 | 53 | 2.1k | |
| Amit K. Mathur | 1642 | 635 | 1318 | 561 | 158 | 2.9k | |
| Raymond Lynch | 1223 | 407 | 644 | 571 | 69 | 2.4k | |
| Xun Luo | 1017 | 1092 | 471 | 1139 | 66 | 2.1k | |
| Janet E. Tuttle‐Newhall | 1156 | 634 | 602 | 747 | 70 | 2.1k | |
| Mary K. Guidinger | 2590 | 1246 | 1850 | 1744 | 34 | 3.8k | |
| Abbas Rana | 1928 | 428 | 1635 | 755 | 139 | 3.0k | |
| John Forsythe | 1535 | 1289 | 465 | 1529 | 124 | 3.3k | |
| Eric K.H. Chow | 1055 | 947 | 439 | 903 | 49 | 2.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...